{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:42:11Z","timestamp":1791013331584,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,6]]},"DOI":"10.7759\/cureus.106509","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:15:04Z","timestamp":1775474104000},"source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Outcomes After Guillain-Barr\u00e9 Syndrome: A Systematic Review of Functional Recovery, Residual Symptoms, and Quality of Life"],"prefix":"10.7759","author":[{"given":"Sharafath Hussain","family":"Zahir Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaw","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review","volume":"31","author":"Bellanti R","year":"2024","unstructured":"Bellanti R, Rinaldi S. Guillain-Barr\u00e9 syndrome: a comprehensive review. Eur J Neurol. 2024, 31:e16365. 10.1111\/ene.16365","journal-title":"Eur J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000445347","article-title":"Fatigue, pain, anxiety and depression in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"75","author":"Merkies IS","year":"2016","unstructured":"Merkies IS, Kieseier BC. Fatigue, pain, anxiety and depression in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol. 2016, 75:199-206. 10.1159\/000445347","journal-title":"Eur Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jns.70022","article-title":"Patient-reported outcome measures for assessing health-related quality of life in patients with polyneuropathies, focusing on Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: a systematic review of measurement properties","volume":"30","author":"Pelouto F","year":"2025","unstructured":"Pelouto F, Baars AE, Papri N, Haagsma JA, Jacobs BC, Terwee CB. Patient-reported outcome measures for assessing health-related quality of life in patients with polyneuropathies, focusing on Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: a systematic review of measurement properties. J Peripher Nerv Syst. 2025, 30:e70022. 10.1111\/jns.70022","journal-title":"J Peripher Nerv Syst"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12209","article-title":"International Guillain-Barr\u00e9 Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr\u00e9 syndrome","volume":"22","author":"Jacobs BC","year":"2017","unstructured":"Jacobs BC, van den Berg B, Verboon C, et al.. International Guillain-Barr\u00e9 Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst. 2017, 22:68-76. 10.1111\/jns.12209","journal-title":"J Peripher Nerv Syst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4314\/mmj.v35i3.4","article-title":"Three-year follow-up outcomes of adult patients with Guillain-Barr\u00e9 syndrome after rehabilitation","volume":"35","author":"Uz FB","year":"2023","unstructured":"Uz FB, Uz C, Karaahmet OZ. Three-year follow-up outcomes of adult patients with Guillain-Barr\u00e9 syndrome after rehabilitation. Malawi Med J. 2023, 35:156-62. 10.4314\/mmj.v35i3.4","journal-title":"Malawi Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123140","article-title":"Long-term outcomes of patients affected by Guillain-Barr\u00e9 syndrome in Colombia after the Zika virus epidemic","volume":"463","author":"Acero-Garces D","year":"2024","unstructured":"Acero-Garces D, Zuluaga-Lotero D, Ortiz-Mu\u00f1oz D, et al.. Long-term outcomes of patients affected by Guillain-Barr\u00e9 syndrome in Colombia after the Zika virus epidemic. J Neurol Sci. 2024, 463:123140. 10.1016\/j.jns.2024.123140","journal-title":"J Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220049","article-title":"Long-term outcomes of Guillain-Barr\u00e9 syndrome possibly associated with Zika virus infection","volume":"14","author":"Walteros DM","year":"2019","unstructured":"Walteros DM, Soares J, Styczynski AR, et al.. Long-term outcomes of Guillain-Barr\u00e9 syndrome possibly associated with Zika virus infection. PLoS One. 2019, 14:e0220049. 10.1371\/journal.pone.0220049","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.04.076","article-title":"Disability and quality of life in Guillain-Barr\u00e9 syndrome - longitudinal study","volume":"78","author":"Berisavac I","year":"2020","unstructured":"Berisavac I, Arsenijevic M, Bozovic I, et al.. Disability and quality of life in Guillain-Barr\u00e9 syndrome - longitudinal study. J Clin Neurosci. 2020, 78:185-8. 10.1016\/j.jocn.2020.04.076","journal-title":"J Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jns5.12051","article-title":"Health-related quality of life in Guillain-Barr\u00e9 syndrome patients: a systematic review","volume":"19","author":"Darweesh SK","year":"2014","unstructured":"Darweesh SK, Polinder S, Mulder MJ, et al.. Health-related quality of life in Guillain-Barr\u00e9 syndrome patients: a systematic review. J Peripher Nerv Syst. 2014, 19:24-35. 10.1111\/jns5.12051","journal-title":"J Peripher Nerv Syst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0269215514549564","article-title":"Balancing everyday life two years after falling ill with Guillain-Barr\u00e9 syndrome: a qualitative study","volume":"29","author":"Forsberg A","year":"2015","unstructured":"Forsberg A, Wid\u00e9n-Holmqvist L, Ahlstr\u00f6m G. Balancing everyday life two years after falling ill with Guillain-Barr\u00e9 syndrome: a qualitative study. Clin Rehabil. 2015, 29:601-10. 10.1177\/0269215514549564","journal-title":"Clin Rehabil"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98501-y","article-title":"Real-world treatment of adult patients with Guillain-Barr\u00e9 syndrome over the last two decades","volume":"11","author":"Rath J","year":"2021","unstructured":"Rath J, Zulehner G, Schober B, Grisold A, Krenn M, Cetin H, Zimprich F. Real-world treatment of adult patients with Guillain-Barr\u00e9 syndrome over the last two decades. Sci Rep. 2021, 11:19170. 10.1038\/s41598-021-98501-y","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325815","article-title":"Intravenous immunoglobulin treatment for mild Guillain-Barr\u00e9 syndrome: an international observational study","volume":"92","author":"Verboon C","year":"2021","unstructured":"Verboon C, Harbo T, Cornblath DR, et al.. Intravenous immunoglobulin treatment for mild Guillain-Barr\u00e9 syndrome: an international observational study. J Neurol Neurosurg Psychiatry. 2021, 92:1080-8. 10.1136\/jnnp-2020-325815","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2024-000925","article-title":"Pain determinants and quality of life in Guillain-Barre syndrome: a prospective cohort study","volume":"6","author":"Papri N","year":"2024","unstructured":"Papri N, Mohammed A, Rahman MM, et al.. Pain determinants and quality of life in Guillain-Barre syndrome: a prospective cohort study. BMJ Neurol Open. 2024, 6:e000925. 10.1136\/bmjno-2024-000925","journal-title":"BMJ Neurol Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila N","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021, 397:1214-28. 10.1016\/S0140-6736(21)00517-1","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg B","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014, 10:469-82. 10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes RA","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barr\u00e9 syndrome. Lancet. 2005, 366:1653-66. 10.1016\/S0140-6736(05)67665-9","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn PA","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008, 7:939-50. 10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012, 366:2294-304. 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies","volume":"12","author":"Kuwabara S","year":"2013","unstructured":"Kuwabara S, Yuki N. Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies. Lancet Neurol. 2013, 12:1180-8. 10.1016\/S1474-4422(13)70215-1","journal-title":"Lancet Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/793024","article-title":"An update in Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Winer JB","year":"2014","unstructured":"Winer JB. An update in Guillain-Barr\u00e9 syndrome. Autoimmune Dis. 2014, 2014:793024. 10.1155\/2014\/793024","journal-title":"Autoimmune Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1572949","article-title":"Evolving understanding of Guillain-Barr\u00e9 syndrome pathophysiology and the central role of the classical complement pathway in axonal injury","volume":"16","author":"Gorson KC","year":"2025","unstructured":"Gorson KC. Evolving understanding of Guillain-Barr\u00e9 syndrome pathophysiology and the central role of the classical complement pathway in axonal injury. Front Neurol. 2025, 16:1572949. 10.3389\/fneur.2025.1572949","journal-title":"Front Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar JJ","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011, 36:123-33. 10.1159\/000324710","journal-title":"Neuroepidemiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.13703","article-title":"Falls in people post-Guillain-Barr\u00e9 syndrome in the United Kingdom: a national cross-sectional survey of community based adults","volume":"30","author":"Davidson I","year":"2022","unstructured":"Davidson I, Parker ZJ. Falls in people post-Guillain-Barr\u00e9 syndrome in the United Kingdom: a national cross-sectional survey of community based adults. Health Soc Care Community. 2022, 30:e2590-603. 10.1111\/hsc.13703","journal-title":"Health Soc Care Community"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-95","article-title":"Guillain-Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases","volume":"13","author":"Gonz\u00e1lez-Su\u00e1rez I","year":"2013","unstructured":"Gonz\u00e1lez-Su\u00e1rez I, Sanz-Gallego I, Rodr\u00edguez de Rivera FJ, Arpa J. Guillain-Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol. 2013, 13:95. 10.1186\/1471-2377-13-95","journal-title":"BMC Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20620","article-title":"Long-term prognosis of Guillain-Barr\u00e9 syndrome not determined by treatment options?","volume":"8","author":"Wang Y","year":"2017","unstructured":"Wang Y, Lang W, Zhang Y, Ma X, Zhou C, Zhang HL. Long-term prognosis of Guillain-Barr\u00e9 syndrome not determined by treatment options?. Oncotarget. 2017, 8:79991-80001. 10.18632\/oncotarget.20620","journal-title":"Oncotarget"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3138\/ptc.2015-58","article-title":"Influence of exercise on patients with Guillain-Barr\u00e9 syndrome: a systematic review","volume":"68","author":"Simatos Arsenault N","year":"2016","unstructured":"Simatos Arsenault N, Vincent PO, Yu BH, Bastien R, Sweeney A. Influence of exercise on patients with Guillain-Barr\u00e9 syndrome: a systematic review. Physiother Can. 2016, 68:367-76. 10.3138\/ptc.2015-58","journal-title":"Physiother Can"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S565907","article-title":"Patient experiences of the biopsychosocial impact of Guillain-Barr\u00e9 syndrome: a scoping review","volume":"19","author":"Susanti V","year":"2025","unstructured":"Susanti V, Trisyani Y, Nuraeni A. Patient experiences of the biopsychosocial impact of Guillain-Barr\u00e9 syndrome: a scoping review. Patient Prefer Adherence. 2025, 19:3755-67. 10.2147\/PPA.S565907","journal-title":"Patient Prefer Adherence"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.20463\/pan.2024.0027","article-title":"Changes in body composition, physical fitness and quality of life on robotic gait assisted training in patients with Guillain-Barr\u00e9 Syndrome: a case report","volume":"28","author":"Lee MJ","year":"2024","unstructured":"Lee MJ, Yoon SJ. Changes in body composition, physical fitness and quality of life on robotic gait assisted training in patients with Guillain-Barr\u00e9 Syndrome: a case report. Phys Act Nutr. 2024, 28:9-14. 10.20463\/pan.2024.0027","journal-title":"Phys Act Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01707-3","article-title":"Guidelines for neuroprognostication in adults with Guillain-Barr\u00e9 syndrome","volume":"38","author":"Busl KM","year":"2023","unstructured":"Busl KM, Fried H, Muehlschlegel S, et al.. Guidelines for neuroprognostication in adults with Guillain-Barr\u00e9 syndrome. Neurocrit Care. 2023, 38:564-83. 10.1007\/s12028-023-01707-3","journal-title":"Neurocrit Care"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.94093","article-title":"Clinical spectrum and prognostic predictors of Guillain-Barr\u00e9 syndrome: a prospective observational study from South India","volume":"17","author":"Ravichandran H","year":"2025","unstructured":"Ravichandran H, Joseph R, Sengar P, et al.. Clinical spectrum and prognostic predictors of Guillain-Barr\u00e9 syndrome: a prospective observational study from South India. Cureus. 2025, 17:e94093. 10.7759\/cureus.94093","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-025-05545-z","article-title":"A structured rehabilitation program for functional recovery in Guillain-Barr\u00e9 syndrome: a case report","volume":"19","author":"Yousef NM","year":"2025","unstructured":"Yousef NM, Adejumo DK, Hazari A, Kandakurti PK. A structured rehabilitation program for functional recovery in Guillain-Barr\u00e9 syndrome: a case report. J Med Case Rep. 2025, 19:450. 10.1186\/s13256-025-05545-z","journal-title":"J Med Case Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2020.5.20200057","article-title":"Guillain-Barre syndrome: demographics, clinical features, and outcome in a single tertiary care hospital, Oman","volume":"25","author":"Al Maawali SM","year":"2020","unstructured":"Al Maawali SM, Al Shibani AY, Nadeem AS, Al-Salti AM. Guillain-Barre syndrome: demographics, clinical features, and outcome in a single tertiary care hospital, Oman. Neurosciences (Riyadh). 2020, 25:369-74. 10.17712\/nsj.2020.5.20200057","journal-title":"Neurosciences (Riyadh)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477228-long-term-outcomes-after-guillain-barr-syndrome-a-systematic-review-of-functional-recovery-residual-symptoms-and-quality-of-life","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:15:04Z","timestamp":1775474104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477228-long-term-outcomes-after-guillain-barr-syndrome-a-systematic-review-of-functional-recovery-residual-symptoms-and-quality-of-life"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.106509","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,6]]}}}